Daily Judi: Monday, August 29, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
In an effort to confront the lack of diversity in clinical trial populations, the Association of Clinical Research Organizations (ACRO) released four diversity and inclusion principles. Committee Chair, Rachael Fones, Director, Government and Public Affairs at IQVIA commented,“ACRO’s Diversity and Inclusion in Clinical Trials committee created these Principles to demonstrate our shared commitment to advancing diversity, equity and inclusion in clinical trials and bring focus to the key actions ACRO and its member companies are taking toward advancing a more inclusive clinical research ecosystem." (Fierce Biotech)
The Internet of things, control tower technology, AI, augmented reality, blockchain; Pharma Logistics IQ takes a look at how technology will transform pharmaceutical supply chains.
Last year, more than 100 biotechnology companies raised nearly $15 billion in IPOs. Biopharma Dive traces the ups and downs of the IPO, amid a change in the market, and offers a live database tracking the numbers.
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
We also hope to see you this September 13-14, in Boston, for DPHARM: Disruptive Innovations to Advance Clinical Trials, walking distance from our North End headquarters.
Our Culture
“Dossiers and redaction are built within the Judi platform, which helps significantly with adjudication management—and the client collaborates on the process.”
–Jess, Program Manager
About Judi
Judi is on a mission to empower the ecosystems that drive clinical trial success by improving their workflows. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
